Safety and Effectiveness of the PXL-Platinum 330 System for CXL Using Riboflavin Solution

Completed · Phase 1

Conditions studied: Keratoconus, Pellucid Marginal Corneal Degeneration, Corneal Degeneration, Corneal Ectasia

In brief

Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Collagen Cross-linking in Eyes With Corneal Thinning Conditions

Key facts

Study ID
NCT04177082
Run by
Cornea Associates of Texas
People needed
200
Starts
2020-01-10
Expected to finish
2022-05-05
Last updated by the study team
2022-10-19

Who can join

Age: 8 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.